Abound Wealth Management’s Bristol-Myers Squibb BMY Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $84.7K | Buy |
1,829
+1,524
| +500% | +$70.6K | 0.02% | 145 |
|
|
2025
Q1 | $18.6K | Sell |
305
-205
| -40% | -$12.5K | 0.01% | 302 |
|
|
2024
Q4 | $28.8K | Buy |
510
+115
| +29% | +$6.51K | 0.01% | 228 |
|
|
2024
Q3 | $20.4K | Buy |
395
+32
| +9% | +$1.65K | 0.01% | 293 |
|
|
2024
Q2 | $15.1K | Sell |
363
-43
| -11% | -$1.79K | 0.01% | 303 |
|
|
2024
Q1 | $22K | Sell |
406
-287
| -41% | -$15.6K | 0.01% | 231 |
|
|
2023
Q4 | $35.6K | Buy |
693
+243
| +54% | +$12.5K | 0.01% | 178 |
|
|
2023
Q3 | $26.1K | Sell |
450
-92
| -17% | -$5.34K | 0.01% | 188 |
|
|
2023
Q2 | $34.7K | Buy |
542
+90
| +20% | +$5.76K | 0.01% | 164 |
|
|
2023
Q1 | $31.3K | Sell |
452
-82
| -15% | -$5.69K | 0.01% | 164 |
|
|
2022
Q4 | $38.4K | Sell |
534
-57
| -10% | -$4.1K | 0.02% | 135 |
|
|
2022
Q3 | $42K | Buy |
+591
| New | +$42K | 0.02% | 128 |
|